We have completed experiments to track the development of dopamine neurons from iPSCs using single cell RNA sequencing. These data have been integrated into a bioinformatic tool, NeuroTest, that will be used to help us evaluate the quality of the patient-specific dopamine neuron replacement therapy that we are developing for Parkinson Disease.